Leukaemia Foundation / HSANZ PhD Scholarships Program
The Leukaemia Foundation is helping more medical and science graduates pursue a research career in blood cancer by combining resources and working in partnership with Haematology Society of Australia and New Zealand (HSANZ) to co-fund PhD research scholarships.
These prestigious doctoral scholarships are awarded to Australian applicants who demonstrate outstanding merit in blood cancer research. They are open to all areas of Australian research in blood cancers and blood cancer related disorders.
Applicants’ work must align with a least one of the Leukaemia Foundation’s three research priorities:
- Implementation science
- Prevention, early detection, and diagnostics
- Therapies and treatment
The PhD scholarship program offers applicants – early career scientists, allied health care professionals, nurses and haematologists – a three-year scholarship with total funding of $150,000.
The PhD scholarship program is administered by HSANZ and uses its existing grants review and selection process with representation from the Leukaemia Foundation.
The selection criteria used by the HSANZ is based on National Health and Medical Research Council scoring.
For more information on eligibility and how to apply, please visit https://hsanz.org.au/PhD-Scholarships.
Applications close midnight (AEST) 26 July 2026.
PhD Scholarship recipients
- Dr Elizabeth Goodall
Improving Patient-Reported Outcomes in patients with lymphoma
- Dr Rithin Nedumannil
Understanding how acute myeloid leukaemia resists menin inhibitor treatment
- Dr Julian Grabek
Improve the understanding of the biology of blood cancers by examining tumour heterogeneity in MPN stem cells
- Dr Khai Li Chai
Immunoglobulin therapy to prevent and treat infections in patients in blood cancers: who, why, when and how?
- Dr Liesl Butler
Development of improved biomarkers and targeted therapies for myeloproliferative neoplasms (MPNs)